To investigate the prognostic value of the expression of ABCC3 in glioma patients, our team performed univariable Cox analyses and observed that ABCC3 (HR = 1.369; 95% CI = 1.306–1.435; P < 0.001), PRS types, histological status, gradation, ages, and chemotherapy were factors related to higher risks and IDH variant and 1p19q codeletion were related to lower risks (Figure 3(a)). This evidence concerns the gene IDH1 and central nervous system cancer.